Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT02112318
Eligibility Criteria:
Inclusion Criteria:
* Recurrent AF verified by at least one ECG recording prior to the index admission
* Known onset of symptoms within 30 days from index admission.
* Sinus rhythm ECG within 30 days prior to the index admission If onset of symptoms is unknown.
* If duration of the present AF episode \>48 hours then thromboembolic risk should be minimized by either verifying that the patient is adequately anticoagulated according to the hospital routine or TEE performed to verify the lack of contraindications for electrical cardioversion.
* Echocardiography at any time since first onset of AF to verify the lack of significant valvular disease.
* Age older than 18 years.
Exclusion Criteria:
* AF due to reversible cause or significant valvular heart disease
* Treatment with class I or III antiarrhythmic drugs within five half-lives of their elimination period. No amiodarone treatment within six months before admission
* Prior ablation of AF
* Unability to verify onset of symptoms within 30 days prior to the index admission
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02112318
Study Brief:
Protocol Section:
NCT02112318